Goosehead Insurance (GSHD)
(Delayed Data from NSDQ)
$90.46 USD
+1.97 (2.23%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $90.39 -0.07 (-0.08%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Goosehead Insurance (GSHD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$76.10 | $100.00 | $41.00 | -14.00% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Goosehead Insurance comes to $76.10. The forecasts range from a low of $41.00 to a high of $100.00. The average price target represents a decline of 14% from the last closing price of $88.49.
Analyst Price Targets (10)
Broker Rating
Goosehead Insurance currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, five are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 45.45% and 18.18% of all recommendations. A month ago, Strong Buy made up 45.45%, while Buy represented 18.18%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Buy | Moderate Buy |
7/25/2024 | Truist Securities | Mark D Hughes | Hold | Hold |
7/25/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
7/24/2024 | Piper Sandler | Paul Newsome | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Andrew S Kligerman | Strong Buy | Strong Buy |
3/28/2024 | BMO Capital Markets | Michael Zaremski | Strong Buy | Strong Buy |
2/21/2024 | JMP Securities | Matthew J Carletti | Strong Buy | Strong Buy |
2/9/2024 | William Blair | Adam Klauber | Hold | Hold |
10/17/2023 | UBS | Brian R Meredith | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 11 |
Average Target Price | $76.10 |
LT Growth Rate | 24.70% |
Industry | Insurance - Multi line |
Industry Rank by ABR | 99 of 252 |
Current Quarter EPS Est: | 0.45 |